Infinity Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US45665G3039

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Anthony B Evnin. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Anthony B Evnin har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AVEO / AVEO Pharmaceuticals Inc Director 0
US:INFI / Infinity Pharmaceuticals Inc. Director 215.403
US:US138098AA66 / CANTEL MEDICAL CORP CONV 3.25% 05/15/2025 144A Director 0
Director 5.742.765
US:JUNO / Juno Therapeutics, Inc. Director 0
US:XLRN / Acceleron Pharma Inc Director 20.000
Director, 10% Owner 25.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Anthony B Evnin. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INFIQ / Infinity Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insidersalg INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INFIQ / Infinity Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-09-30 INFI EVNIN ANTHONY B 112.451 13,5635 112.451 13,5635 1.525.229 364 7.9250 -634.055 -41,57
2013-12-02 INFI EVNIN ANTHONY B 17.756 14,5600 17.756 14,5600 258.527
2013-11-27 INFI EVNIN ANTHONY B 1.200 14,5600 1.200 14,5600 17.472
2013-11-26 INFI EVNIN ANTHONY B 138.961 14,7200 138.961 14,7200 2.045.506
2013-11-25 INFI EVNIN ANTHONY B 23.703 15,4000 23.703 15,4000 365.026
2012-11-29 INFI EVNIN ANTHONY B 4.832 24,6187 4.832 24,6187 118.958
2012-11-27 INFI EVNIN ANTHONY B 17.648 25,2817 17.648 25,2817 446.171

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Anthony B Evnin som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-01-19 2023-01-19 4 AVEO AVEO PHARMACEUTICALS, INC.
Common Stock
D - Sale to Issuer -41.841 0 -100,00 15,00 -627.615
2022-06-16 2022-06-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 46.378 215.403 27,44 0,68 31.491 146.259
2021-06-11 2021-06-10 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30.000 30.000
2021-06-11 2021-06-10 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 3.061 169.025 1,84 3,43 10.499 579.756
2021-06-09 2021-06-09 4 AVEO AVEO PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 12.500 12.500
2021-06-02 2021-06-02 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
D - Sale to Issuer -12.132 0 -100,00 80,59 -977.718
2020-07-31 2020-07-31 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
A - Award 1.935 12.132 18,98
2020-06-30 2020-06-10 4 AVEO AVEO PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2020-06-18 2020-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30.000 30.000
2020-06-18 2020-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 22.826 165.964 15,95
2020-03-27 2020-03-26 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
P - Purchase 1.300 10.197 14,61 37,40 48.620 381.368
2020-03-27 2020-03-26 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
P - Purchase 1.200 8.897 15,59 40,37 48.444 359.172
2019-12-16 2019-12-13 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 400.000 5.742.765 7,49 34,50 13.800.000 198.125.392
2019-10-04 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 2.823.529 5.342.765 112,08 8,50 23.999.996 45.413.502
2019-08-02 2019-07-31 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
A - Award 713 7.697 10,21
2019-06-14 2019-06-13 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30.000 30.000
2019-06-14 2019-06-13 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 13.125 143.138 10,10 1,60 21.000 229.021
2019-06-13 2019-06-12 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 40.000 40.000
2019-06-10 2019-06-06 4 CNST CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 13.171 13.171
2018-11-26 2018-11-21 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
P - Purchase 109 109 2,05 223 223
2018-11-16 2018-11-16 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
S - Sale -151.035 0 -100,00 1,82 -274.400
2018-11-16 2018-11-15 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
S - Sale -670.894 151.035 -81,62 1,86 -1.248.265 281.016
2018-11-16 2018-11-14 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
S - Sale -325.139 821.929 -28,35 1,90 -617.862 1.561.912
2018-08-10 2018-07-31 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
A - Award 712 6.984 11,35
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -10.000.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
C - Conversion -1.208.674 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -888.888 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -664.894 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -3.750.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -9.500.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 133.334 2.519.236 5,59 15,00 2.000.010 37.788.540
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 2.385.902 2.385.902
2018-06-19 2018-06-18 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 40.000 40.000
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 11.428 130.013 9,64 1,75 19.999 227.523
2018-03-07 2018-03-05 4 JUNO Juno Therapeutics, Inc.
Director Stock Option (Right to Buy)
D - Sale to Issuer -12.000 0 -100,00 63,71 -764.520
2018-03-07 2018-03-05 4 JUNO Juno Therapeutics, Inc.
Director Stock Option (Right to Buy)
D - Sale to Issuer -12.000 0 -100,00 44,60 -535.200
2018-03-07 2018-03-05 4 JUNO Juno Therapeutics, Inc.
Director Stock Option (Right to Buy)
D - Sale to Issuer -12.000 0 -100,00 27,00 -324.000
2018-03-07 2018-02-14 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -34.842 0 -100,00
2018-03-07 2018-02-09 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -25.000 34.842 -41,78
2018-01-09 2018-01-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 150 59.842 0,25
2017-10-06 2017-10-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 161 59.692 0,27
2017-08-01 2017-07-31 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
A - Award 510 6.272 8,85
2017-07-07 2017-07-06 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -7.000 59.531 -10,52
2017-07-07 2017-07-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 230 66.531 0,35
2017-06-23 2017-06-21 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 57.857 57.857
2017-06-23 2017-06-21 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2017-06-21 2017-06-20 4 JUNO Juno Therapeutics, Inc.
Common Stock
P - Purchase 9.000 66.301 15,71 24,40 219.600 1.617.744
2017-06-19 2017-06-16 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 11.494 118.585 10,73 1,74 20.000 206.338
2017-04-06 2017-04-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 311 57.301 0,55
2017-03-30 2017-03-28 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
J - Other 250.000 418.414 148,44 0,50 125.000 209.207
2017-03-17 2017-03-15 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
P - Purchase 2.500 5.762 76,64 77,88 194.691 448.723
2017-03-13 2017-03-10 4 JUNO Juno Therapeutics, Inc.
Common Stock
P - Purchase 8.000 56.990 16,33 22,11 176.885 1.260.083
2017-01-19 2017-01-18 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
P - Purchase 2.000 3.262 158,48 76,26 152.525 248.769
2017-01-09 2017-01-05 4 CMD CANTEL MEDICAL CORP
Common Stock, par value $.10 per share
A - Award 1.262 1.262
2017-01-09 2017-01-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 715 48.990 1,48
2017-01-09 2017-01-06 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40.000 40.000
2017-01-09 3 CMD CANTEL MEDICAL CORP
Common Stock, part value $.10 per share
0
2016-10-17 2016-10-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 485 48.275 1,01
2016-08-25 2016-08-23 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -10.937 47.790 -18,62
2016-07-05 2016-07-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 363 58.727 0,62
2016-06-21 2016-06-17 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2016-06-21 2016-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2016-06-21 2016-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-06-21 2016-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 13.157 107.091 14,01 1,52 19.999 162.778
2016-05-31 2016-05-26 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 44.021 44.021
2016-05-31 2016-05-26 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2016-05-17 2016-05-13 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock Warrants (right to buy)
A - Award 129.533 129.533
2016-05-17 2016-05-13 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 129.533 168.414 333,15
2016-04-07 2016-04-05 4 JUNO Juno Therapeutics, Inc.
Common Stock
A - Award 364 58.364 0,63
2016-03-30 2016-03-28 4 JUNO Juno Therapeutics, Inc.
Common Stock
P - Purchase 4.054 58.000 7,51 36,94 149.739 2.142.294
2016-03-30 2016-03-28 4 JUNO Juno Therapeutics, Inc.
Common Stock
P - Purchase 3.946 53.946 7,89 36,22 142.923 1.953.908
2016-03-30 2016-03-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -15.000 50.000 -23,08
2015-12-18 2015-12-15 4 JUNO Juno Therapeutics, Inc.
Common Stock
G - Gift -10.000 65.000 -13,33
2015-09-03 2015-09-01 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 2.034 93.934 2,21 8,60 17.492 807.832
2015-07-29 2015-07-27 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -146.614 0 -100,00 47,82 -7.011.081
2015-07-29 2015-07-27 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -80.740 146.614 -35,51 48,26 -3.896.512 7.075.592
2015-06-29 2015-06-26 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -31.225 583.333 -5,08 48,31 -1.508.480 28.180.817
2015-06-29 2015-06-26 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -78.395 614.558 -11,31 47,55 -3.727.682 29.222.233
2015-06-29 2015-06-26 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -173.713 692.953 -20,04 46,57 -8.089.814 32.270.821
2015-06-29 2015-06-25 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -1.800 866.666 -0,21 50,99 -91.782 44.191.299
2015-06-29 2015-06-25 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -85.800 868.466 -8,99 50,26 -4.312.308 43.649.101
2015-06-29 2015-06-25 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -71.725 954.266 -6,99 49,19 -3.528.153 46.940.345
2015-06-29 2015-06-25 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -140.675 1.025.991 -12,06 48,39 -6.807.263 49.647.704
2015-06-19 2015-06-18 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -50.269 1.166.666 -4,13 53,58 -2.693.413 62.509.964
2015-06-19 2015-06-18 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -154.495 1.216.935 -11,27 52,74 -8.148.066 64.181.152
2015-06-19 2015-06-18 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -78.569 1.371.430 -5,42 52,07 -4.091.088 71.410.360
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -12.000 1.449.999 -0,82 56,32 -675.840 81.663.944
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -11.602 1.461.999 -0,79 55,85 -647.972 81.652.644
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -28.603 1.473.601 -1,90 54,70 -1.564.584 80.605.975
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -63.574 1.502.204 -4,06 53,84 -3.422.824 80.878.663
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -94.080 1.565.778 -5,67 52,65 -4.953.312 82.438.212
2015-06-19 2015-06-17 4 JUNO Juno Therapeutics, Inc.
Common Stock
S - Sale X -90.141 1.659.858 -5,15 51,59 -4.650.374 85.632.074
2015-06-16 2015-06-12 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2015-06-16 2015-06-15 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2015-06-16 2015-06-15 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2015-06-01 2015-05-28 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option(right to buy)
A - Award 20.000 20.000
2015-04-06 2015-04-02 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right-to-buy)
A - Award 25.155 25.155
2015-01-06 2015-01-02 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 8.025 38.881 26,01 0,88 7.062 34.215
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -1.749.999 0 -100,00
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Common Stock
C - Conversion 1.749.999 1.749.999
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150.000
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150.000
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -1.000 1.000 -50,00
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -7.500 7.500 -50,00
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -6.000 0 -100,00
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.000 91.900 1,10 11,85 11.850 1.089.015
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7.500 90.900 8,99 11,85 88.875 1.077.165
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.000 83.400 13,62 12,94 129.400 1.079.196
2014-10-06 2014-10-03 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.000 73.400 8,90 12,94 77.640 949.796
2014-10-02 2014-09-30 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -112.451 0 -100,00 13,56 -1.525.229
2014-10-02 2014-10-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 6.305 30.856 25,68 1,12 7.062 34.559
2014-07-02 2014-07-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 3.901 24.551 18,89 1,81 7.061 44.437
2014-06-23 2014-06-19 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 12.500 12.500
2014-06-19 2014-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2014-06-19 2014-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2014-04-02 2014-04-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 4.556 20.650 28,31 1,55 7.062 32.008
2014-01-06 2014-01-02 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 3.923 16.094 32,23 1,80 7.061 28.969
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 20.000 20.000
2013-12-04 2013-12-02 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -17.756 112.451 -13,64 14,56 -258.527 1.637.287
2013-11-27 2013-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.200 130.207 -0,91 14,56 -17.472 1.895.814
2013-11-27 2013-11-26 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -138.961 131.407 -51,40 14,72 -2.045.506 1.934.311
2013-11-27 2013-11-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -23.703 270.368 -8,06 15,40 -365.026 4.163.667
2013-10-03 2013-10-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 3.395 12.171 38,69 2,08 7.062 25.316
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series F Convertible Preferred Stock
C - Conversion -79.617 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series E Convertible Preferred Stock
J - Other -118.240 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series D Convertible Preferred Stock
C - Conversion -39.175 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series C Convertible Preferred Stock
C - Conversion -293.143 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series B Convertible Preferred Stock
C - Conversion -507.665 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Series A Convertible Preferred Stock
C - Conversion -1.376.249 0 -100,00
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
C - Conversion 79.617 2.496.152 3,29
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
J - Other 190.571 2.416.535 8,56
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
C - Conversion 39.175 2.225.964 1,79
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
C - Conversion 293.143 2.186.789 15,48
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
C - Conversion 507.665 1.893.646 36,63
2013-09-26 2013-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
C - Conversion 1.376.249 1.385.981 14.141,48
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
9.732
2013-07-02 2013-07-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 2.758 8.776 45,83 2,56 7.060 22.467
2013-06-12 2013-06-11 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 2.000 2.000
2013-06-12 2013-06-11 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2013-05-30 2013-05-29 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 12.500 12.500
2013-04-24 2013-04-01 4 AVEO AVEO PHARMACEUTICALS INC
Common Stock
A - Award 1.034 6.018 20,75 7,25 7.496 43.630
2013-04-10 2012-11-26 4/A INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
J - Other 8.743 67.400 14,91
2012-11-29 2012-11-29 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -4.832 294.071 -1,62 24,62 -118.958 7.239.646
2012-11-29 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -17.648 298.903 -5,58 25,28 -446.171 7.556.776
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -6.000 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5.625 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5.625 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.375 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.375 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.375 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.407 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.875 0 -100,00
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.000 59.580 11,20 6,80 40.800 405.144
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.000 53.580 22,95 6,80 68.000 364.344
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.625 43.580 14,82 6,74 37.912 293.729
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.375 37.955 32,80 6,74 63.188 255.817
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.625 28.580 24,50 5,63 31.669 160.905
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.375 22.955 69,04 5,63 52.781 129.237
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.375 13.580 222,95 7,70 72.188 104.566
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.407 4.205 50,29 9,23 12.987 38.812
2012-11-28 2012-11-27 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.875 2.798 203,14 15,04 28.200 42.082
2012-11-28 2012-11-26 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
J - Other 923 923
2012-11-28 2012-11-26 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
J - Other 4.832 316.551 1,55
2012-11-28 2012-11-26 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
J - Other -864.565 311.719 -73,50
2012-07-03 2012-07-02 4 PARS PHARMOS CORP
Stock Option (right to buy)
A - Award 25.000 25.000
2012-06-12 2012-05-30 4 AVEO AVEO PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 12.500 12.500
2012-05-17 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2012-05-17 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 6.000 6.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)